Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00382226Phase 4Completed
Phase 4, randomised, double-blind trial in Glaucoma and ocular hypertension comparing Azopt + TTFC with Placebo + TTFC (2 arms). Primary endpoint: Intraocular Pressure at 12 weeks. Started Sep 2006; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00382226.